Adlyxin
Generic name: Lixisenatide
Drug class:
Incretin mimetics
Usage of Adlyxin
Adlyxin is an injectable diabetes medicine that helps control blood sugar levels. This medication helps your pancreas produce insulin more efficiently.
Adlyxin is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
Adlyxin is not for treating type 1 diabetes.
Adlyxin side effects
Get emergency medical help if you have signs of an allergic reaction to Adlyxin: hives, itching, severe rash; rapid heartbeats; trouble swallowing; difficult breathing; feeling light-headed; swelling of your face, lips, tongue, or throat.
Stop using this medicine and call your doctor at once if you have:
Common Adlyxin side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Adlyxin
You should not use Adlyxin if you are allergic to lixisenatide, or if you have diabetic ketoacidosis (call your doctor for treatment).
To make sure Adlyxin is safe for you, tell your doctor if you have:
Tell your doctor if you are pregnant or breastfeeding.
Follow your doctor's instructions about using this medicine if you are pregnant or you become pregnant. Controlling diabetes is very important during pregnancy, and having high blood sugar may cause complications in both the mother and the baby.
Adlyxin can make birth control pills less effective. If you take a birth control pill, take it at least 1 hour before or 11 hours after you use Adlyxin.
Adlyxin is not approved for use by anyone younger than 18 years old.
Relate drugs
- Adlyxin
- Albiglutide
- Bydureon
- BYDUREON BCise
- Bydureon Pen
- Byetta
- Dulaglutide
- Exenatide
- Exenatide extended release
- Liraglutide
- Lixisenatide
- Mounjaro
- Ozempic
- Rybelsus
- Saxenda
- Semaglutide
- Semaglutide (Oral)
- Semaglutide (Subcutaneous)
- Tanzeum
- Tirzepatide
- Trulicity Pen
- Victoza
- Wegovy
How to use Adlyxin
Usual Adult Dose for Diabetes Type 2:
Initial dose: 10 mcg subcutaneously once a day for 14 days Maintenance dose: Increase to 20 mcg subcutaneously once a day on day 15, and thereafter Comments: -This drug should be administered within 1 hour before the first meal of the day, preferably the same meal each day; if a dose is missed, administer within 1 hour prior to the next meal. -Concurrent use with short acting insulin has not been studied and is not recommended. Use: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Warnings
Stop using Adlyxin and call your doctor at once if you have nausea and vomiting with severe pain in your upper stomach spreading to your back.
Never share an injection pen, cartridge, or syringe with another person, even if the needle has been changed.
What other drugs will affect Adlyxin
Adlyxin can slow your digestion, and it may take longer for your body to absorb any medicines you take by mouth.
Other drugs may interact with lixisenatide, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Popular FAQ
Soliqua is a combination of insulin glargine plus lixisenatide, and Lantus only contains insulin glargine. Both are once-daily injections that are given under the skin (subcutaneously), but Soliqua can only be used in adults with type 2 diabetes whereas Lantus may be used to treat both type 1 and type 2 diabetes in adults and children over the age of six years. Both are made by Sanofi-Aventis. Continue reading
Both Soliqua and Xultophy combine a long-acting insulin with a GLP-1 agonist: Xultopy brings together Tresiba (insulin degludec) and Victoza (liraglutide), while Soliqua combines Lantus (insulin glargine) with Adlyxin (lixisenatide). When used with diet and exercise for the treatment of type 2 diabetes, these agents can help you control blood sugar, insulin levels, and digestion and may help you lose weight. Continue reading
Adlyxin (lixisenatide) is injected once a day. It is injected under the skin (subcutaneously) into the abdomen, thigh or upper arm. It should be injected at the same time each day and within one hour before the first meal of the day. Continue reading
Soliqua is a combination of insulin glargine plus lixisenatide, and Lantus only contains insulin glargine. Both are once-daily injections that are given under the skin (subcutaneously), but Soliqua can only be used in adults with type 2 diabetes whereas Lantus may be used to treat both type 1 and type 2 diabetes in adults and children over the age of six years. Both are made by Sanofi-Aventis. Continue reading
Both Soliqua and Xultophy combine a long-acting insulin with a GLP-1 agonist: Xultopy brings together Tresiba (insulin degludec) and Victoza (liraglutide), while Soliqua combines Lantus (insulin glargine) with Adlyxin (lixisenatide). When used with diet and exercise for the treatment of type 2 diabetes, these agents can help you control blood sugar, insulin levels, and digestion and may help you lose weight. Continue reading
Adlyxin (lixisenatide) is injected once a day. It is injected under the skin (subcutaneously) into the abdomen, thigh or upper arm. It should be injected at the same time each day and within one hour before the first meal of the day. Continue reading
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions